Argenx Se
(NASDAQ) ARGX
Argenx Se Financials at a Glance
Market Cap
$54.99B
Revenue (TTM)
$6.29B
Net Income (TTM)
$2.33B
EPS (TTM)
$19.58
P/E Ratio
42.12
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Price
$888.45
Volume
17,679
Open
$895.01
Price
$888.45
Volume
17,679
Open
$895.01
Previous Close
$888.45
Daily Range
$880.73 - $906.52
52-Week Range
$510.06 - $934.62
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Price
$888.45
Volume
17,679
Open
$895.01
Previous Close
$888.45
Daily Range
$880.73 - $906.52
52-Week Range
$510.06 - $934.62
Estimated Earnings Date
Jul 23, 2026
ARGX News
Best Biotech ETFs to Buy in 2026
Is Argenx Stock a Buy Now?
ARGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Argenx Se
Industry
Biotechnology
Sector
Health CareEmployees
1,863
CEO
Tim van Hauwermeiren, EMBA
Website
www.argen-x.comHeadquarters
Amsterdam, 1101EB, NL
ARGX Financials
Key Financial Metrics (TTM)
Gross Margin
89.00%
Operating Margin
25.64%
Net Income Margin
33.42%
Return on Equity
16.82%
Return on Capital
14.24%
Return on Assets
13.00%
Earnings Yield
2.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$54.99B
Shares Outstanding
61.88M
Volume
17.68K
Avg. Volume
341.62K
Financials (TTM)
Gross Profit
$5.09B
Operating Income
$1.31B
EBITDA
$1.29B
Operating Cash Flow
$762.90M
Capital Expenditure
-$7.95M
Free Cash Flow
$754.95M
Cash & ST Invst.
$4.44B
Total Debt
$83.49M
Argenx Se Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.21B
+459.2%
Gross Profit
$2.87B
+457.3%
Gross Margin
89.40%
N/A
Market Cap
$54.99B
N/A
Market Cap/Employee
$34.39M
N/A
Employees
1,599
N/A
Net Income
$1.05B
+1045.0%
EBITDA
$673.36M
+659.1%
Quarterly Fundamentals
Total Cash
$4.44B
+39.6%
Total Debt
$83.49M
+317.4%
Accounts Receivable
$1.66B
+231.9%
Inventory
$473.53M
+52.5%
Long Term Debt
$72.65M
+373.2%
Short Term Debt
$10.83M
+133.2%
Return on Assets
13.00%
N/A
Return on Invested Capital
11.76%
N/A
Free Cash Flow
$406.90M
+400.9%
Operating Cash Flow
$407.80M
+402.3%